Literature DB >> 19855143

Surgical treatment of a dural arteriovenous fistula in the superior petrosal sinus of an elderly patient with minimal suboccipital craniotomy: case report.

Toshikazu Kimura1, Masaaki Shojima, Tomoyuki Koizumi, Syunsuke Fukaya, Yasumitsu Ichikawa, Akio Morita.   

Abstract

An 85-year-old woman presented with a dural arteriovenous fistula of the superior petrosal sinus manifesting as venous infarction of the cerebellum. Magnetic resonance imaging and angiography revealed right cerebellar swelling, venous engorgement, and an arteriovenous fistula in the superior petrosal sinus. Our initial attempt to obliterate the lesion through a transvenous endovascular approach failed, so we successfully treated the fistula via surgical interruption of the superior petrosal vein through a small suboccipital craniotomy. Careful examination of the pattern of venous drainage is important to determine surgical indications. This case indicates that minimally invasive open surgery can be effective even in an elderly patient.

Entities:  

Mesh:

Year:  2009        PMID: 19855143     DOI: 10.2176/nmc.49.465

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  3 in total

Review 1.  The superior petrosal sinus: a review of anatomy, embryology, pathology, and neurosurgical relevance.

Authors:  Martin M Mortazavi; Marcus A Cox; Erfanul Saker; Sanjay Krishnamurthy; Ketan Verma; Christoph J Griessenauer; Marios Loukas; Rod J Oskouian; R Shane Tubbs
Journal:  Neurosurg Rev       Date:  2016-09-19       Impact factor: 3.042

2.  Delayed dural arteriovenous fistula after microvascular decompression for hemifacial spasm.

Authors:  Sung Han Kim; Won Seok Chang; Hyun Ho Jung; Jin Woo Chang
Journal:  J Korean Neurosurg Soc       Date:  2014-08-31

Review 3.  Endovascular treatment for dural arteriovenous fistulas in the petroclival region.

Authors:  Kun Hou; Xianli Lv; Lai Qu; Yunbao Guo; Kan Xu; Jinlu Yu
Journal:  Int J Med Sci       Date:  2020-10-18       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.